Searchable abstracts of presentations at key conferences in endocrinology

ea0022p291 | Diabetes | ECE2010

Coagulation inhibitors in type 2 diabetes mellitus

Thisiadou Katerina , Karamouzis Ioannis , Arampatzi Stella , Lazaridou Despoina

Background: Diabetes mellitus (DM) is related to hypercoagulability.The predisposition for thrombosis disorders is caused by increased accumulation of platelets, by high concentrations of prothrombotic factors and by the reduced concentration and activity of the inhibitor factors. Abnormalities of coagulation inhibitors have been reported in many studies on diabetes over the last years, but unfortunately, the results have often appeared contradictory.</p...